AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9009296
Drug: CVD 908-htrA
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 908-htrA and CVD 906-htrA vaccine strains at doses of 5 x 10(8) to 5 x 10(9) CFU
Trial: 9009296
Drug: CVD 908-htrA
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 908-htrA and CVD 906-htrA vaccine strains
Trial: 9009296
Drug: CVD 908-htrA
RxNorm normalized name: Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVD 908-htrA and CVD 906-htrA vaccine strains at higher doses
Trial: 28834248
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA; 75 mg)
Trial: 28834248
Drug: Ibuprofen (IBU;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (IBU; 1200 mg)
Trial: 26518190
Drug: Metformin 1000
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1000 mg taken with a meal (Met protocol)
Trial: 18250365
Drug: Dietary nitrate
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary nitrate load (beetroot juice 500 mL)
Trial: 11826763
Drug: Urinary follicle-stimulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary follicle-stimulating hormone (FSH)
Trial: 8113458
Drug: Isotretinoin 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin 0.1% cream applied twice daily for 24 weeks
Trial: 25183453
Drug: Beer (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beer (30 g alcohol/d, 660 mL)
Trial: 25183453
Drug: Non‐alcoholic beer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non‐alcoholic beer (990 mL)
Trial: 25183453
Drug: Gin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gin (30 g alcohol/d, 100 mL)
Trial: 9342580
Drug: Valsartan (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (160 mg) + Atenolol (100 mg)
Trial: 2674029
Drug: Zopiclone (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone (7.5 mg/per os/day)
Trial: 2674029
Drug: Nitrazepam (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam (5.0 mg/per os/day)
Trial: 4731336
Drug: Amitriptyline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (10 to 60 mg, usually taken at night)
Trial: 23220855
Drug: Oral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paracetamol (Group OP)
Trial: 21496253
Drug: High-dose tranexamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose tranexamic acid (TA)
Trial: 26291137
Drug: FF/VI 100/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FF/VI 100/25 mcg
Trial: 16850247
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel plus trastuzumab (4 mg/kg loading dose, then weekly 2 mg/kg)
Trial: 16850247
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel alone (80 mg/m2)
Trial: 16850247
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel plus trastuzumab
Trial: 12161089
Drug: Baseline and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline and follow-up surveys on intervention dose
Trial: 9612600
Drug: Intravenous 131I-polyclonal
RxNorm normalized name: iobenguane (131I)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous 131I-polyclonal antiferritin (added to either regimen)
Trial: 7927192
Drug: Pyridostigmine (PD),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine (PD), 120 mg po
Trial: 7927192
Drug: Hydrocortisone succinate
RxNorm normalized name: Hydrocortisone succinate
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone succinate infusion (100 mg bolus followed by 250 mg infusion)
Trial: 2521027
Drug: Nicardipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (5 mg)
Trial: 30705602
Drug: S-8117 (controlled-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-8117 (controlled-release oxycodone)
Trial: 18198636
Drug: Routine Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine Western medicine treatment
Trial: 7552649
Drug: Full-time, intensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-time, intensive 3-week multidisciplinary program, including active physical and ergonomic training and psychological pain management, followed by 1 day weekly for the subsequent 3 weeks
Trial: 7552649
Drug: Active physical
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active physical training, twice a week for 6 weeks, for a total of 24h
Trial: 7552649
Drug: Psychological pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological pain management combined with active physical training, twice a week for 6 weeks, also for a total of 24h
Trial: 20634639
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment for 6 and 12 months
Trial: 20634639
Drug: Matched controls
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched controls (no GH treatment)
Trial: 17685990
Drug: Healthcare site
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Healthcare site (alcohol treatment need)
Trial: 15563363
Drug: Multidisciplinary service
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary service model delivering medication review including GP education, patient home visits, pharmacist medication reviews, primary healthcare team conferences, GP implementation of action plans, and follow-up surgery visits.
Trial: 2979271
Drug: Kreon (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kreon (3.6 g/day)
Trial: 354397
Drug: Timolol ophthalmic
RxNorm normalized name: timolol ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol ophthalmic solution
Trial: 3678263
Drug: Amiodarone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (200 mg day-1)
Trial: 24520744
Drug: Distal vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distal vein patch modification
Trial: 21160018
Drug: Arthroscopic rotator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arthroscopic rotator cuff repair without augmentation
Trial: 19069461
Drug: alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-lipoic acid (600 mg/day)
Trial: 19069461
Drug: mexidol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mexidol (300 mg/day)
Trial: 16596054
Drug: Controlled hyperthyroidism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled hyperthyroidism on medical therapy (group B)
Trial: 1442643
Drug: Formal hypnosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formal hypnosis with different treatment strategies (groups one and two)
Trial: 31751012
Drug: Comparator EGFR-TKIs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator EGFR-TKIs (gefitinib at 250 mg once daily or erlotinib at 150 mg once daily)
Trial: 29576358
Drug: PAS (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAS (400 mg PS & 400 mg PA per day)
Trial: 25682232
Drug: Tiotropium 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 5 μg
Trial: 27578478
Drug: Placebo 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 2.5 μg
Trial: 17956932
Drug: Nurse-led treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led treatment (after 7 sessions)
Trial: 8260372
Drug: Sequential ifosfamide/carboplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential ifosfamide/carboplatin
Trial: 18831897
Drug: Diltiazem (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (90 mg twice daily)
Trial: 2188774
Drug: Oxycodone hydrochloride
RxNorm normalized name: Oxycodone Hydrochloride
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone hydrochloride
Trial: 27479098
Drug: Complicated Grief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complicated Grief Treatment (CGT)
Trial: 24974864
Drug: Calcium Hydroxide
RxNorm normalized name: Calcium Hydroxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Hydroxide preceded by Low Level Laser Therapy (LLLT + CH)
Trial: 24067553
Drug: CYD-TDV (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD-TDV (3 doses at 0, 6, and 12 months)
Trial: 11397724
Drug: 450 mL
RxNorm normalized name: ALCOHOL 270 mL in 450 mL EXTRACORPOREAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mL of black tea initially, followed by 900 mL daily for 4 weeks
Trial: 30034230
Drug: TIO+OLO 5/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIO+OLO 5/5 μg
Trial: 27173787
Drug: PR therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PR therapy
Trial: 24836914
Drug: Reading and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reading and language intervention (two 9-week blocks of daily intervention delivered by trained teaching assistants)
Trial: 15807187
Drug: Pulse therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse therapy (2 microg oral Alfacalcidol twice or thrice weekly)
Trial: 15807187
Drug: Daily therapy
RxNorm normalized name: Konsyl Daily Therapy Fiber Laxative 625mg Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily therapy (0.5 microg oral Alfacalcidol per day)
Trial: 6358652
Drug: Pulse therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse therapy
Trial: 12211526
Drug: Autologous hematopoietic
RxNorm normalized name: Autologous Hematopoietic Peripheral Blood Stem Cells
DrugBank: Autologous Hematopoietic Peripheral Blood Stem Cells (DB17067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous hematopoietic stem cell transplantation (HSCT) following high-dose chemotherapy
Trial: 10180718
Drug: Albuterol inhaled
RxNorm normalized name: albuterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol inhaled from the piezoelectric device (PED)
Trial: 10180718
Drug: Albuterol inhaled
RxNorm normalized name: albuterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol inhaled from the metered dose inhaler (MDI)
Trial: 30337921
Drug: HFA‐BDP metered‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA‐BDP metered‐dose inhaler (MDI) ETN (n = 11)
Trial: 9467248
Drug: Intravenous load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous load of hypertonic glucose solution
Trial: 19717844
Drug: Warfarin (adjusted-dose)
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin (adjusted-dose)
Trial: 23446086
Drug: Control solutions
RxNorm normalized name: Accu-Chek Comfort Curve Control Solutions
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solutions containing no diclofenac
Trial: 16127039
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg administered intravenously
Trial: 12122921
Drug: NK1 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NK1 receptor antagonists
Trial: 8274583
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion (Control)
Trial: 2125794
Drug: Baseline (No
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline (No infusion)
Trial: 807094
Drug: Formula diets
RxNorm normalized name: CIDER VINEGAR DIET FORMULA CAP/TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula diets varying in protein and calorie content (100 or 175 kcal/kg and 1 or 4 g/kg)
Trial: 807094
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 100,000 IU water-miscible vitamin A palmitate
Trial: 807094
Drug: Stabilization period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stabilization period with fluids, antibiotics, and increasing intake of protein and calories to 1 g protein and 100 kcal/kg
Trial: 31843425
Drug: Therapeutic alliance
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic alliance during treatment
Trial: 31034032
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus aspirin (600 mg loading dose on day 1 followed by 75 mg daily for days 2-90)
Trial: 31034032
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (50 to 325 mg/d)
Trial: 16763533
Drug: Iloprost (28-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloprost (28-day intravenous treatment)
Trial: 28768785
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TXA) 1000 mg intravenously
Trial: 19634510
Drug: Test preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test preparation (clopidogrel 75 mg)
Trial: 19634510
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation (clopidogrel 75 mg)
Trial: 19634510
Drug: Test preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test preparation (CBS)
Trial: 19634510
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation (CBS)
Trial: 16942589
Drug: Doxazosin GITS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin GITS 4 mg q.i.d.
Trial: 16942589
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg q.i.d.
Trial: 11356438
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg mifepristone followed by 400 mg oral misoprostol (home administration)
Trial: 11356438
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg mifepristone followed by 400 mg oral misoprostol (clinic administration)
Trial: 8204244
Drug: 80 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 micrograms/kg of preservative‐free epidural morphine with 40 micrograms/kg of butorphanol
Trial: 8204244
Drug: 80 micrograms/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 micrograms/kg of preservative‐free epidural morphine
Trial: 14676074
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium (500 mg)
Trial: 22174811
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg per day of monomeric and oligomeric flavanols (MOF) from grape seeds
Trial: 12775425
Drug: Topotecan treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan treatment
Trial: 26076387
Drug: I-gel (IG)
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-gel (IG)
Trial: 9521334
Drug: Abciximab therapy
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab therapy and low-dose, weight-adjusted heparin
Trial: 9521334
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and standard-dose heparin
Trial: 6897633
Drug: Continuous chlorambucil/prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous chlorambucil/prednisolone therapy (A)
Trial: 6897633
Drug: Continuous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuous low-dose prednimustine (B)
Trial: 6897633
Drug: Intermittent high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent high-dose prednimustine (C)
Trial: 27305192
Drug: Tenofovir disoproxil
RxNorm normalized name: Tenofovir Disoproxil
DrugBank: Tenofovir disoproxil (DB00300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenofovir disoproxil fumarate (TDF) 300 mg per day from 30 to 32 weeks of gestation until postpartum week 4
Trial: 27305192
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care without antiviral therapy
Trial: 25216842
Drug: Fixed-dose combinations
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combinations (FDCs)
Trial: 1901200
Drug: Separate drugs
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate drugs
Trial: 15818697
Drug: Infliximab (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (3 mg/kg or 10 mg/kg every 4 or 8 weeks) plus methotrexate (MTX)
Trial: 9849280
Drug: Suxamethonium 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 1.0 mg.kg‐1
Trial: 9849280
Drug: Rocuronium 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 1.0 mg.kg‐1
Trial: 7905719
Drug: Oral propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol (2 x 80 mg/day)
Trial: 28966878
Drug: FTM ratings
RxNorm normalized name: Aratinga erythrogenys feather extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTM ratings and digitizing tablet
Trial: 18063874
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antifungal prophylaxis)
Trial: 18082206
Drug: 2.5% transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% transdermal dihydrotestosterone gel daily for 3 months (group 1)
Trial: 15871014
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate preparation
Trial: 14569404
Drug: Carob pulp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carob pulp preparation (15 g/d)
Trial: 10389803
Drug: OND pretreatment
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OND pretreatment (4 mg in 2 mg/mL solution)
Trial: 27562742
Drug: Integrase inhibitor
RxNorm normalized name: Integrase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrase inhibitor regimen (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
Trial: 27562742
Drug: Protease inhibitor
RxNorm normalized name: Protease inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitor based regimen
Trial: 27562742
Drug: Integrase inhibitor
RxNorm normalized name: Integrase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrase inhibitor regimen
Trial: 22580040
Drug: Scopoletin (equivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopoletin (equivalent dose present in AFE)
Trial: 8556173
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation therapy
Trial: 7353472
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of methamphetamine
Trial: 31594077
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with HBsAg < 3,000 IU/ml at 24 weeks of treatment.
Trial: 27840148
Drug: Primary angioplasty
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary angioplasty with radial access, bivalirudin, thromboaspiration, drug-eluting stents
Trial: 18024668
Drug: Blood transfusion
RxNorm normalized name: Blood transfusion, auxiliary products
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusion therapy
Trial: 15619132
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution containing 300 mg flecainide and 20 mg cisapride
Trial: 29477795
Drug: S-1 (40,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 (40, 50, or 60 mg twice daily for four of six weeks for up to four cycles)
Trial: 29477795
Drug: gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemcitabine (1000 mg/m2 weekly for three of four weeks for up to six cycles)
Trial: 27027929
Drug: Ivermectin 200 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin 200 μg/kg body weight single oral dose, repeated after one week.
Trial: 27027929
Drug: Benzyl benzoate
RxNorm normalized name: Benzyl Benzoate
DrugBank: Benzyl benzoate (DB00676)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzyl benzoate 20% cream.
Trial: 27027929
Drug: Permethrin 2.5%‐5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permethrin 2.5%‐5% lotion.